UNM Cancer Center administration for the CCSG involves three sets of integrated teams: 1) the research administration team led by Rae Ahn Paden, the Associate Director of Research Administration and Dr. Larry Sklar, Associate Director of Basic Research;2) the shared resource team led by Dr. Scott Ness;and 3) the Clinical Research Committee led by Dr. Robert Hromas, the Deputy Director for Clinical Affairs and Translational Research. These teams are coordinated through the Senior Leadership Executive Committee that sets priorities for the UNM Cancer Center through frequent meetings and an annual budget hearing with appropriate team representatives. UNM Cancer Center Research Administration (CCRA) supports 117 UNM Cancer Center Members, the four research programs and the six shared resources as well as a full complement of clinical trial and support activities. CCRA provides key services to facilitate and enhance scientific productivity and collaboration. CCRA, through Cancer Center Fiscal Services and CFO Bradley Mucek provides pre- and post-award management of grants and contracts and financial management of university and foundation accounts. CCRA through Paden also develops and maintains the Cancer Center portion of the UNM computer network, maintains Cancer Center databases and infomnatics infrastructure, oversees human resource management, the strategic planning process, and the research buildings. The Research Administration Team is responsible for: 1) coordinating seminars, including the monthly Distinguished Cancer Research lecture;2) disseminating notices of research events through email and a web-based calendar;3) disseminating notices of external and internal funding opportunities;4) planning, co-ordination and execution of multiproject program grants;5) supporting Cancer Center Research Programs by scheduling and staffing meetings, recording meeting minutes, maintaining membership lists, organizing program retreats;6) coordinating faculty recruiting visits with Cancer Center members and Academic or Clinical Departments;7) coordinating the annual Cancer Center retreat and workshops;8) coordinating ESAB meetings;and 9) supporting activities related to the CCSG including data bases, extramural funding tables, biosketches and publications for the Cancer Center research website and the CCSG. The Shared Resource Team oversees Shared Resources by maintaining databases of Shared Resource users, services, fees, and grant support for the CCSG. In conjunction with Cancer Center administration the team is responsible for 1) supporting research infrastructure;2) coordinating faculty effort and salary support for UNM Cancer Center and the home department of the Resource Directors;3) tracking resource support as distributed throughout the institution, tracking resource revenues and expenses, and developing business plans;4) creating an interface for Resource users by tracking usage, generating invoices, and implementing the co-pay mechanism;5) centralizing resource ordering, receiving, and service agreements and 6) monthly planning meetings with shared resource directors. The Clinical Research Committee sen/es as the oversight committee for all clinical research at the Cancer Center. To implement strategic planning, quality control, and co-ordination it oversees: 1) CPDMI, 2) Protocol Review and Monitoring System, 3) Protocol Specific Research Support, 4) Data Safety and Monitoring, and 5) the clinical working groups.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of New Mexico Health Sciences Center
United States
Zip Code
Flook, Adam M; Yang, Jianquan; Miao, Yubin (2014) Substitution of the Lys linker with the ?-Ala linker dramatically decreased the renal uptake of 99mTc-labeled Arg-X-Asp-conjugated and X-Ala-Asp-conjugated ?-melanocyte stimulating hormone peptides. J Med Chem 57:9010-8
Davies, Suzy; Holmes, Anna; Lomo, Lesley et al. (2014) High incidence of ErbB3, ErbB4, and MET expression in ovarian cancer. Int J Gynecol Pathol 33:402-10
Wu, Yang; Tapia, Phillip H; Jarvik, Jonathan et al. (2014) Real-time detection of protein trafficking with high-throughput flow cytometry (HTFC) and fluorogen-activating protein (FAP) base biosensor. Curr Protoc Cytom 67:Unit 9.43.
Morris, K T; Khan, H; Ahmad, A et al. (2014) G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration. Br J Cancer 110:1211-20
Vaughan, Roger A; Gannon, Nicholas P; Garcia-Smith, Randi et al. (2014) ?-alanine suppresses malignant breast epithelial cell aggressiveness through alterations in metabolism and cellular acidity in vitro. Mol Cancer 13:14
Lu, Jie; Hathaway, Helen J; Royce, Melanie E et al. (2014) Introduction of D-phenylalanine enhanced the receptor binding affinities of gonadotropin-releasing hormone peptides. Bioorg Med Chem Lett 24:725-30
Campen, Matthew J; Paffett, Michael L; Colombo, E Sage et al. (2014) Muscle RING finger-1 promotes a maladaptive phenotype in chronic hypoxia-induced right ventricular remodeling. PLoS One 9:e97084
Yang, Jianquan; Flook, Adam M; Feng, Changjian et al. (2014) Linker modification reduced the renal uptake of technetium-99m-labeled Arg-Ala-Asp-conjugated alpha-melanocyte stimulating hormone peptide. Bioorg Med Chem Lett 24:195-8
Hill, Jeff W; Thompson, Jeffrey F; Carter, Mark B et al. (2014) Identification of isoxsuprine hydrochloride as a neuroprotectant in ischemic stroke through cell-based high-throughput screening. PLoS One 9:e96761
Scaling, Allison L; Prossnitz, Eric R; Hathaway, Helen J (2014) GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast. Horm Cancer 5:146-60

Showing the most recent 10 out of 123 publications